JENNIFER PICONE: Open Payments
NPI 1437432648 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 16 payments from 11 companies in 2025. Trend: 2023 $914 · 2024 $575 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 3 | $46 |
| PFIZER INC. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Contego Medical, Inc | 1 | $22 |
| Boston Scientific Corporation | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: UPTRAVI, ELIQUIS, LEQVIO, Adempas, WATCHMAN FLX, Kerendia, NEXLETOL, Dexcom G6 Transmitter.
Industry payments across LA — which companies pay providers there.
